Scholarlink

<p>The advancement of multifunctional nanocarriers is crucial for improving cancer treatment. This study explores the synthesis, characterization, molecular modeling, and in vitro evaluation of MnO<sub>2</sub>-based nanocatalysts (MnO<sub>2</sub>, MnO<sub>2</sub>@CeO<sub>2</sub>, and MnO<sub>2</sub>@CeO<sub>2</sub>-Vin-Ser) designed to enhance anticancer activity through synergistic mechanisms. Physicochemical analyses confirmed the successful incorporation of cerium oxide (CeO<sub>2</sub>), vincristine (Vin), and sericin (Ser) into MnO<sub>2</sub>, with sericin playing a vital role in improving nanocarrier stability in aqueous and biological environments. This stability enabled the controlled release of vincristine, ensuring prolonged therapeutic effects.In vitro studies on A549 lung cancer cells demonstrated concentration- and time-dependent cytotoxicity, with MnO<sub>2</sub>@CeO<sub>2</sub>-Vin-Ser exhibiting the highest potency. At 48&#xa0;h, IC50 values decreased to 100&#xa0;μg/ml, 50&#xa0;μg/ml, and 25&#xa0;μg/ml for MnO<sub>2</sub>, MnO<sub>2</sub>@CeO<sub>2</sub>, and MnO<sub>2</sub>@CeO<sub>2</sub>-Vin-Ser, respectively. Cellular uptake studies confirmed effective internalization of MnO<sub>2</sub>@CeO<sub>2</sub>-Vin-Ser at pH 6, mediated by charge reversal and sericin-facilitated endocytosis, leading to DNA damage and apoptosis. Apoptosis analysis revealed selective activation of apoptotic pathways with minimal necrosis, reducing inflammatory risks. Reactive oxygen species (ROS) measurements indicated oxidative stress induction by MnO<sub>2</sub>@CeO<sub>2</sub>, while sericin mitigated excessive ROS production. These findings highlight MnO<sub>2</sub>@CeO<sub>2</sub>-Vin-Ser as a promising nanoplatform for targeted, effective cancer therapy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Sericin-coated MnO2@CeO2 nanocatalysts enable pH-responsive and synergistic vincristine delivery for lung cancer therapy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月11日

查看全文
  • Kiana Bahrehmand,
  • Sajad Moradi,
  • Shokoufeh Rahmani,
  • Elham Arkan,
  • Faranak Aghaz

摘要

The advancement of multifunctional nanocarriers is crucial for improving cancer treatment. This study explores the synthesis, characterization, molecular modeling, and in vitro evaluation of MnO2-based nanocatalysts (MnO2, MnO2@CeO2, and MnO2@CeO2-Vin-Ser) designed to enhance anticancer activity through synergistic mechanisms. Physicochemical analyses confirmed the successful incorporation of cerium oxide (CeO2), vincristine (Vin), and sericin (Ser) into MnO2, with sericin playing a vital role in improving nanocarrier stability in aqueous and biological environments. This stability enabled the controlled release of vincristine, ensuring prolonged therapeutic effects.In vitro studies on A549 lung cancer cells demonstrated concentration- and time-dependent cytotoxicity, with MnO2@CeO2-Vin-Ser exhibiting the highest potency. At 48 h, IC50 values decreased to 100 μg/ml, 50 μg/ml, and 25 μg/ml for MnO2, MnO2@CeO2, and MnO2@CeO2-Vin-Ser, respectively. Cellular uptake studies confirmed effective internalization of MnO2@CeO2-Vin-Ser at pH 6, mediated by charge reversal and sericin-facilitated endocytosis, leading to DNA damage and apoptosis. Apoptosis analysis revealed selective activation of apoptotic pathways with minimal necrosis, reducing inflammatory risks. Reactive oxygen species (ROS) measurements indicated oxidative stress induction by MnO2@CeO2, while sericin mitigated excessive ROS production. These findings highlight MnO2@CeO2-Vin-Ser as a promising nanoplatform for targeted, effective cancer therapy.